- Home
- JAZZ vs BOKF Comparison
JAZZ vs BOKF Comparison
Compare JAZZ & BOKF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- BOKF
- Stock Information
- Founded
- JAZZ 2003
- BOKF 1910
- Country
- JAZZ Ireland
- BOKF United States
- Employees
- JAZZ N/A
- BOKF N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- BOKF Major Banks
- Sector
- JAZZ Health Care
- BOKF Finance
- Exchange
- JAZZ Nasdaq
- BOKF Nasdaq
- Market Cap
- JAZZ 6.7B
- BOKF 6.0B
- IPO Year
- JAZZ 2007
- BOKF N/A
- Fundamental
- Price
- JAZZ $110.27
- BOKF $103.86
- Analyst Decision
- JAZZ Strong Buy
- BOKF Hold
- Analyst Count
- JAZZ 12
- BOKF 11
- Target Price
- JAZZ $183.08
- BOKF $111.55
- AVG Volume (30 Days)
- JAZZ 651.1K
- BOKF 234.3K
- Earning Date
- JAZZ 07-30-2025
- BOKF 07-21-2025
- Dividend Yield
- JAZZ N/A
- BOKF 2.19%
- EPS Growth
- JAZZ 49.21
- BOKF 26.68
- EPS
- JAZZ 7.51
- BOKF 8.72
- Revenue
- JAZZ $4,064,808,000.00
- BOKF $2,087,418,000.00
- Revenue This Year
- JAZZ $6.05
- BOKF $5.98
- Revenue Next Year
- JAZZ $4.68
- BOKF $7.47
- P/E Ratio
- JAZZ $14.72
- BOKF $11.93
- Revenue Growth
- JAZZ 5.76
- BOKF 7.09
- 52 Week Low
- JAZZ $95.49
- BOKF $85.08
- 52 Week High
- JAZZ $148.06
- BOKF $121.58
- Technical
- Relative Strength Index (RSI)
- JAZZ 52.75
- BOKF 67.70
- Support Level
- JAZZ $109.27
- BOKF $101.26
- Resistance Level
- JAZZ $112.70
- BOKF $105.32
- Average True Range (ATR)
- JAZZ 2.72
- BOKF 2.41
- MACD
- JAZZ 0.42
- BOKF 0.74
- Stochastic Oscillator
- JAZZ 67.81
- BOKF 87.81
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About BOKF BOK Financial Corporation
BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.